These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 16406980)

  • 1. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.
    Freedland SJ; Platz EA; Presti JC; Aronson WJ; Amling CL; Kane CJ; Terris MK
    J Urol; 2006 Feb; 175(2):500-4; discussion 504. PubMed ID: 16406980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
    Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
    Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
    Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
    BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and prostate enlargement in men with localized prostate cancer.
    Kopp RP; Han M; Partin AW; Humphreys E; Freedland SJ; Parsons JK
    BJU Int; 2011 Dec; 108(11):1750-5. PubMed ID: 21736693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index as a predictor of prostate cancer: development versus detection on biopsy.
    Freedland SJ; Terris MK; Platz EA; Presti JC
    Urology; 2005 Jul; 66(1):108-13. PubMed ID: 15992911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and capsular incision at the time of open retropubic radical prostatectomy.
    Freedland SJ; Grubb KA; Yiu SK; Nielsen ME; Mangold LA; Isaacs WB; Epstein JI; Partin AW
    J Urol; 2005 Nov; 174(5):1798-801; discussion 1801. PubMed ID: 16217290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
    Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
    Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and screening PSA levels among men undergoing an annual physical exam.
    Rundle A; Neugut AI
    Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
    Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK
    Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004.
    Werny DM; Thompson T; Saraiya M; Freedman D; Kottiri BJ; German RR; Wener M
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):70-6. PubMed ID: 17179487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index influences prostate-specific antigen in men younger than 60 years of age.
    Kim YJ; Han BK; Hong SK; Byun SS; Kim WJ; Lee SE
    Int J Urol; 2007 Nov; 14(11):1009-12. PubMed ID: 17956528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and risk of biochemical progression following radical prostatectomy at a tertiary care referral center.
    Freedland SJ; Grubb KA; Yiu SK; Humphreys EB; Nielsen ME; Mangold LA; Isaacs WB; Partin AW
    J Urol; 2005 Sep; 174(3):919-22. PubMed ID: 16093988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].
    Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of body mass index and prostate-specific antigen in a population-based study.
    Baillargeon J; Pollock BH; Kristal AR; Bradshaw P; Hernandez J; Basler J; Higgins B; Lynch S; Rozanski T; Troyer D; Thompson I
    Cancer; 2005 Mar; 103(5):1092-5. PubMed ID: 15668913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database.
    Freedland SJ; Bañez LL; Sun LL; Fitzsimons NJ; Moul JW
    Prostate Cancer Prostatic Dis; 2009; 12(3):259-63. PubMed ID: 19581922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.